BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0022
0.00 (0.00%)
May 22, 2026, 5:02 PM CET
BioSenic Company Description
BioSenic S.A., a biotech company, focuses on developing clinical assets.
Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis.
The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures.
The company is based in Mont-Saint-Guibert, Belgium.
Contact Details
Address: Avenue Léon champagne, 3 Saintes Belgium | |
| Phone | 32 478 27 68 42 |
Stock Details
| Ticker Symbol | BIOS |
| Exchange | Euronext Brussels |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | BE0974280126 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jean-Luc Vandebroek | Interim Chief Executive Officer and Director |